Advanced search
Start date
Betweenand

Microalga for biopharmaceuticals production, their characterization, and nanocarrier systems for Atopic Dermatitis treatment

Grant number: 24/13605-2
Support Opportunities:Scholarships in Brazil - Doctorate
Start date: October 01, 2025
End date: July 31, 2028
Field of knowledge:Biological Sciences - Microbiology - Applied Microbiology
Principal Investigator:Lívia Seno Ferreira Camargo
Grantee:Juliana Tonini
Host Institution: Centro de Ciências Naturais e Humanas (CCNH). Universidade Federal do ABC (UFABC). Santo André , SP, Brazil

Abstract

Atopic dermatitis is a chronic disease that impacts the quality of life of individuals and often requires systemic, immunomodulatory, and immunosuppressive therapy, although these treatments can cause toxicity and inadequate response. In view of this, biological drugs are more specific and generate fewer side effects compared to traditional treatments. Recombinant biological drugs are predominantly produced in mammalian cells. However, it is interesting to search for alternative platforms that offer advantages in terms of cost and production methods. In this case, microalgae can be used as an alternative and sustainable expression platform. Among microalgae, Chlamydomonas reinhardtii has been widely studied in the field of genetic engineering, showing characteristics for producing molecules of different complexities. Thus, the present project aims at the genetic transformation of the Chlamydomonas reinhardtii chloroplast for the expression of the anti-IL-4/IL-13 monoclonal antibody and the antimicrobial peptide Omiganan. The results will be obtained through the application of molecular biology techniques such as PCR, cloning, genetic transformation with glass beads, and western blotting. Additionally, a nanoplatform composed of natural-origin components with wound-healing and anti-inflammatory properties will be produced, capable of modulating the release and permeation of drugs through the skin. These nanoplatforms will be characterized and evaluated for their stability, cytotoxicity, and treatment performance. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)